Showing results (151-160 of 696) with videos related to

Sort By:
Pageof 70
Clinical Kidney Journal|August 12, 2024
The validity of pathology codes for biopsy-confirmed kidney disease in the Danish National PatobankMarie Møller, Iain Bressendorff, Rikke Borg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
Optimal dose of losartan for renoprotection in diabetic nephropathySteen Andersen, Peter Rossing, Tina R Juhl, et al.
Diabetes|May 5, 2009
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort studyPeter Hovind, Peter Rossing, Lise Tarnow, et al.
Diabetes, Obesity & Metabolism|November 6, 2024
The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney diseaseJohannes David Smeijer, Maria F Gomez, Peter Rossing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trialPeter Rossing, Jorma Strand, Angelo Avogaro, et al.
Diabetes Research and Clinical Practice|June 30, 2023
Glucagon-like peptide-1 treatment reduces the risk of diabetes-type 2 related amputations: A cohort study in DenmarkZeinab Schäfer, Andreas Mathisen, Trine Rolighed Thomsen, et al.
Current Obesity Reports|October 4, 2016
Global Changes in Food Supply and the Obesity EpidemicEmilie H Zobel, Tine W Hansen, Peter Rossing, et al.
Diabetes Care|June 10, 2024
Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.SPeter Rossing, Per-Henrik Groop, Rakesh Singh, et al.
Nephron|October 9, 2023
Techniques to Assess the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Blood Volume in Patients with Diabetic Kidney DiseaseVårin Vinje, Tobias Bomholt, Peter Rossing, et al.
Diabetes & Vascular Disease Research|October 20, 2022
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosisElisabeth B Stougaard, Peter L Kristensen, Urd Kielgast, et al.
Pageof 70